banner add

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

October 03, 2024 0
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.

from NYT > Health https://ift.tt/HO1FV4S
via IFTTT
Tags:

No comments

Subscribe to: Post Comments ( Atom )

Brenna Henn Wanted to Improve Genetic Medicine. Then Her N.I.H. Grant Was Cut.

Brenna Henn had a long-term grant to study the genetic diversity of Africans and people of African descent. Then her N.I.H. funding was cut....

Theme images by PLAINVIEW. Powered by Blogger.